Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Dropbox Inc
DBX
Technology
Software - Application
Dropbox, Inc. provides tools to help distributed teams prioritize, get organized, and keep work moving securely from anywhere. Its products include Dropbox Passwords, Vault, Computer Backup, Dropbox Sign, DocSend, Dropbox Capture and FormSwift, among others. Dropbox Passwords allows users to sign into Websites and apps by creating and storing usernames and passwords across devices. Dropbox...
Vault helps secure and organize sensitive information in the cloud. Computer backup automatically syncs folders on a user's computer to the cloud. Dropbox Sign is an e-signature and document workflow platform that enables customers to easily sign, send and receive documents through its intuitive Web and mobile-based interfaces. DocSend is a secure document sharing and analytics platform. Dropbox Capture is an all-in-one visual communication tool that helps team members share their work and ideas asynchronously. Its customers include individuals, families, teams, and organizations of all sizes.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:DBX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(0)
•••
GraceLee
X
View Profile
View Bullboard History
Post by
GraceLee
on Apr 13, 2023 4:21am
Kevin Harrington Discusses FSD Pharma
I believe this new product will aid society in reducing the
...more
(0)
•••
GraceLee
X
View Profile
View Bullboard History
Post by
GraceLee
on Jul 15, 2022 9:53pm
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA
posted Apr 25, 2024 9:00am by
Indiva Ltd
-
|
“Net Income was just shy of break-even in Q4, which is a testament to the popularity of our products, our industry leading low-cost production platform, and our focus on cost control. Our core brands, namely Pearls by Grön, No Future, Bhang Chocolate and Indiva Blips continue to gain market share in Canada, as Indiva continues to hold the #1 market share position in edibles nationally," said ...read more
(0)
•••
GraceLee
X
View Profile
View Bullboard History
Post by
GraceLee
on Jun 03, 2022 5:38am
FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance
(0)
•••
GraceLee
X
View Profile
View Bullboard History
Post by
GraceLee
on Jun 02, 2022 12:47am
FSD Pharma Files Investigational New Drug Application “IND”
(0)
•••
GraceLee
X
View Profile
View Bullboard History
Post by
GraceLee
on May 11, 2022 2:04am
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
(0)
•••
GraceLee
X
View Profile
View Bullboard History
Post by
GraceLee
on May 03, 2022 11:14pm
Lucid-MS for Multiple Sclerosis Treatment
(0)
•••
GraceLee
X
View Profile
View Bullboard History
Post by
GraceLee
on Apr 26, 2022 6:28am
"Julia Levy Award" Recipient David Allan and Dr. John McGraw
(0)
•••
GraceLee
X
View Profile
View Bullboard History
Post by
GraceLee
on Apr 19, 2022 11:41pm
FSD Pharma Inc: Lucid MS Video
FSD Pharma is delighted to announce pre-clinical findings
...more
(0)
•••
GraceLee
X
View Profile
View Bullboard History
Post by
GraceLee
on Apr 09, 2022 1:05pm
FSD: Cancellation of Certain Shares Issued to Former CEO
FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)
...more
(0)
•••
GraceLee
X
View Profile
View Bullboard History
Post by
GraceLee
on Apr 07, 2022 12:54pm
FSD Pharma Issues Corporate Updates
FSD Pharma Issues Corporate Updates TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to
...more
(0)
•••
GraceLee
X
View Profile
View Bullboard History
Post by
GraceLee
on Apr 06, 2022 2:16am
iMining: First Hospital Foundation in Decentraland Metaverse
iMining Enters into Agreement for the First-Ever Hospital Foundation to Be Launched in the Decentraland Metaverse Vancouver, British Columbia--(Newsfile Corp.) - iMining Technologies Inc
...more
(0)
•••
GraceLee
X
View Profile
View Bullboard History
Post by
GraceLee
on Feb 19, 2022 2:24am
FSD Pharma; Recapping 2021 and What to Look Forward in 2022
(0)
•••
GraceLee
X
View Profile
View Bullboard History
Post by
GraceLee
on Feb 04, 2022 11:24am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is pleased to share pre-clinical data demonstrating the effectiveness of its lead drug candidate, Lucid-MS, in treating Multiple Sclerosis. The unique potential therapeutic value of Lucid
...more
(0)
•••
GraceLee
X
View Profile
View Bullboard History
Post by
GraceLee
on Jan 01, 2022 1:26am
FSD Pharma Announces Share Repurchase Program
FSD Pharma Announces Share Repurchase Program TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding
...more
(0)
•••
GraceLee
X
View Profile
View Bullboard History
Post by
GraceLee
on Dec 10, 2021 10:07am
FSD Pharma Establishes New Regulatory Advisory Board
FSD Pharma Establishes New Regulatory Advisory Board with the Appointment of Joga Gobburu, Ph.D., and Mary Melnyk, Ph.D., as Members Regulatory Advisory Board will oversee the drug development
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Stage Set for Creation of a Leading Intermediate Gold Producer
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil